Rapid Micro Biosystems, Inc. is a life sciences technology company. The company is headquartered in Lexington, Massachusetts and currently employs 171 full-time employees. The company went IPO on 2021-07-15. Its flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in pharmaceutical manufacturing operations. The company offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.
Mr. Robert Spignesi est le President de Rapid Micro Biosystems, Inc, il a rejoint l'entreprise depuis 2014.
Quelle est la performance du prix de l'action RPID ?
Le prix actuel de RPID est de $2.01, il a diminué de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Rapid Micro Biosystems, Inc ?
Rapid Micro Biosystems, Inc appartient à l'industrie Life Sciences Tools & Services et le secteur est Health Care
Quel est la capitalisation boursière de Rapid Micro Biosystems, Inc ?
La capitalisation boursière actuelle de Rapid Micro Biosystems, Inc est de $91.9M
Est-ce que Rapid Micro Biosystems, Inc est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 4 analystes ont établi des notations d'analystes pour Rapid Micro Biosystems, Inc, y compris 3 achat fort, 6 achat, 1 maintien, 0 vente et 3 vente forte